The FDA Killed Flavored Vapes and Approved Flavored Nicotine Pouches in the Same Six Weeks. Nicotine Didn't Get Safer. The Delivery Device Did.

If you are the parent of a teenager, or you were a teenager with a vape in your backpack more recently than you’d like to admit, you already know the flavors that mattered were never tobacco or menthol. They were the sweet ones — mango, blue raspberry, watermelon ice — the ones a 16-year-old’s palate is built to want and a 45-year-old two-pack-a-day smoker mostly isn’t shopping for. That distinction sat at the center of two FDA decisions issued five days apart in late June 2026, and the agency landed on opposite sides of it depending on whether the product was inhaled or tucked under a lip.

On June 25, the Fifth Circuit upheld the FDA’s denial of marketing applications from Triton Distribution and Vapetasia for their menthol-flavored e-cigarettes, ruling the agency had reasonably concluded that the products’ benefit to adult smokers trying to quit didn’t outweigh the risk of hooking a new generation of teenagers. Five days earlier, on June 30, the FDA cleared twenty Zyn nicotine-pouch products — Cinnamon, Coffee, Citrus, Cool Mint, Wintergreen among them — to carry a “modified risk” label claiming that switching from cigarettes to Zyn lowers your risk of mouth cancer, heart disease, stroke, and emphysema.

Same nicotine. Same flavor palette built to appeal past an adult’s decision-making and straight to a teenager’s. Two federal rulings, six days apart, that treated flavor as disqualifying in one product and irrelevant in the other.

The legal standard is the same. The application of it wasn’t.

Both decisions run through the same statutory gate: a nicotine product needs to be “appropriate for the protection of the public health” to get FDA authorization, weighing the benefit to adult smokers who switch against the risk of pulling in new underage users. The Fifth Circuit’s Triton ruling wasn’t a rogue lower-court outcome — it was the Fifth Circuit falling in line with the U.S. Supreme Court, which had already unanimously tossed out an earlier, more vape-industry-friendly version of the same circuit’s reasoning in April 2025. On remand, applying the standard the way the Supreme Court told it to, the Fifth Circuit found the FDA had done its job: flavored vapes carry a documented youth-appeal risk substantial enough that Triton and Vapetasia’s evidence of adult-smoker benefit didn’t clear the bar.

Judges on the Fifth Circuit panel had pressed FDA’s counsel hard on this exact tension during oral argument earlier this year, asking why the agency’s flavor-risk reasoning for e-cigarettes wouldn’t apply with equal force to other flavored nicotine products already on the market — a question the June 25 opinion answers only by staying inside the four corners of the PMTA pathway Triton and Vapetasia applied through, not the modified-risk pathway Zyn used.

Zyn cleared that different pathway, on paper — the “modified risk” pathway, which asks whether a product is measurably less harmful than the cigarettes a smoker would otherwise use, not whether it’s authorized to be sold at all in the first place. Zyn products have been legally on shelves for years; June 30 only changed what the label is allowed to claim. That’s a real, defensible legal distinction. It is a much thinner distinction if you are the parent of a teenager who has never smoked a cigarette in their life, has no cigarette habit to be “modified” away from, and is choosing between a flavored vape their friend says is banned now and a flavored pouch the FDA just put a health claim on.

The pattern is older than either of these products

We have watched federal regulators carve flavor exceptions out of tobacco policy under industry pressure before, and it is worth remembering exactly how, because the shape repeats. When Congress passed the Family Smoking Prevention and Tobacco Control Act in 2009, it banned flavored cigarettes outright — candy, fruit, clove — as a documented youth-recruitment tool. It left one flavor standing: menthol, in combustible cigarettes, the single flavor category with the deepest entrenchment among adult smokers and the most powerful lobby behind it. Menthol cigarettes went on being sold to teenagers for another sixteen years while every other flavored cigarette disappeared from shelves, until the FDA finally moved to ban menthol combustibles in the 2020s under a different set of political winds. The lesson from 2009 wasn’t that regulators don’t understand flavor risk. It’s that which flavors survive regulatory scrutiny tracks the size and organization of the industry defending them at least as closely as it tracks the underlying public-health evidence — and the nicotine-pouch industry, still young and still growing, has spent the years since 2009 building exactly the kind of lobbying and evidentiary infrastructure that kept menthol cigarettes alive for a decade and a half.

When Congress passed the Family Smoking Prevention and Tobacco Control Act in 2009, it banned flavored cigarettes outright — candy, fruit, clove — as a documented youth-recruitment tool.

What this actually means if you’re trying to help someone quit — or keep a kid from starting

For a provider or case manager, the practical read isn’t “vapes bad, pouches fine” — the modified-risk data on Zyn versus combustible cigarettes is real, and switching an adult smoker to a smokeless nicotine product is a legitimate harm-reduction move worth discussing, the same way switching someone from fentanyl to buprenorphine is. The practical read is narrower: your intake screening for nicotine use needs to ask about pouches specifically, not just vaping and cigarettes, because a product the FDA just told the public is “modified risk” reads to most patients as “not really a nicotine dependence” — and that’s not what the label means. It means less risk than a cigarette, not low risk, and it says nothing at all about a teenager who never smoked picking one up because a friend passed it around at lunch.

If you’re the person cutting back on cigarettes and Zyn is part of how you’re doing it, the modified-risk data holds up, and that’s a real step — the direction, not the discomfort of the method, is what your lungs care about. If you’re the parent wondering why a can of flavored pouches sits easier with the FDA than a flavored vape cartridge, you’re not misreading the regulatory landscape. You’re reading it correctly. The agency drew the line by product category and evidentiary pathway, not by whether either product was built, in flavor and marketing, to appeal to someone your kid’s age. That gap between the legal reasoning and the plain-language read a family gives it is exactly where nicotine policy has lived for going on two decades now — and closing it was never going to happen in a single June.